Finnish outsourcing specialist Pihlajalinna posted some reasonable looking financials, on the face of it, for the full year to January 31, 2021 on Friday last week - so why have its shares dropped around 11% at the time of writing?
Pan-Nordic care group Attendo achieved modest revenue growth in 2021, whilst its occupancy level almost recovered to pre-pandemic levels. But it made a slight loss after taxes and its share price at SEK30.17 is down 70% from the 2017 peak.
In July 2021, Finland’s leftist parliament passed the long-awaited SOTE reform to its healthcare system, which amalgamated 309 municipal health authorities into 21 much larger ‘welfare regions’. HBI speaks to analysts and operators to find out what impact the reform is having on the for-profit sector.
Terveystalo, one of Finland’s two for-profit healthcare giants, saw strong growth in 2021, helped by its recent move into Sweden and a Covid boost. We speak to Terveystalo’s head of investor relations and two analysts, to analyse growth drivers.
Clinisys claims to have created the world’s largest player in lab information management and lab order comms and results software with a three-way merger which creates a platform across diagnostics and environmental tests. So how does CEO, Michael Simpson, see software changing the sector over the next 3-5 years? And what does an independent consultant with many years experience in the field think about the sector and its growth?
CVC Capital Partners has agreed to acquire a co-controlling holding in pan-European IVF provider FutureLife, alongside the company’s current investor Hartenberg Holding.
Adult social care, a major sector in the UK and Nordics in particular, has traditionally been dominated by the not-for-profit sector in Europe. In this week's infographic, we look at the for-profit, not-for-profit/public split across select countries in Europe.
Finland's largest for-profit healthcare operator by revenue Mehiläinen has made its first acquisition in Germany. The acquired hospital, Dalberg Klinik, is the ticket to further investments in the country's outpatient sector, HBI hears from Janne-Olli Järvenpää, Mehiläinen's CEO.
The Finnish competition regulator has approved Mehiläinen's acquisition of Vetrea's residential care business, showing that the big groups can still push for greater market share.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy